Guest guest Posted April 25, 2005 Report Share Posted April 25, 2005 Neurologist examines the complexities of MS By Joanne Fox Journal staff writer Although there is no cure for multiple sclerosis (MS), Dr. F. Pary of Sioux City is enthusiastic about emerging treatments for this condition. " What I like about this disease is that once you diagnose it, you can treat it with drugs that can reduce the chance of further attacks, " he said enthusiastically. " There are also several symptomatic treatments for problems related to MS that can improve patients' quality of life. " It's the reason the 31-year-old native of Brazil decided to study neurology, which is his specialty at CNOS, the Center for Neurosciences Orthopaedics & Spine, PC, in Dakota Dunes. " I always wanted to be in medicine, " he reflected, with just a hint of a Portuguese accent. " Neurology really interested me because I felt I could really help my patients from being disabled. " That is the reality of MS, a disease of the central nervous system (which includes the brain, the spinal cord and the optic nerves) that may last for years and eventually can cause serious disabilities, including paralysis and loss of vision. In its initial stages, individuals may experience weakness, numbness and/or tingling in their extremities; extreme fatigue, vision loss, double vision, unexplained dizziness or difficulty walking. MS could be characterized as a stealth disease, because many times, people will look and act perfectly normal for much of the time. Individuals with symptoms of multiple sclerosis need to call their doctor for further evaluation as many of these symptoms may also be caused by other neurological disorders. " Any of these symptoms should warrant a check-up with a physician, " Pary insisted. " The diagnosis is clinical, but tests like a brain MRI and lumbar puncture are also helpful in confirming MS and excluding other disorders that may mimic it. " Surrounding and protecting the nerve fibers of the central nervous system is a fatty tissue called myelin, which helps the nerve fibers conduct electrical impulses. In MS, myelin is lost, leaving scar tissue. The brain MRI (Magnetic Resonance Imaging) shows the physician " multiple " areas of demyelinization and scar (sclerosis), hence the term multiple sclerosis. When the myelin is damaged or destroyed, the ability of the nerves to function is disrupted and that causes the various symptoms of MS. " Neurologists are trained to determine if a symptom like weakness is secondary to a brain, nerve or muscle disorder, " said Pary, referring to the confusion between multiple sclerosis and muscular dystrophy, a disease of the skeletal muscles that causes weakness and stiffness. " A good history and exam can help the neurologist decide what tests should be used to diagnose a brain or muscle disorder. When evaluating multiple sclerosis, I usually order a lumbar puncture and brain MRI to be sure the symptoms are not being caused by another condition that may look like MS. " Pary emphasized the need for appropriate testing to exclude diseases that mimic MS. Those include Lyme Disease, a tick-borne illness characterized by flu-like symptoms and joint pain; sarcoidosis, a multisystemic disease that can affect a variety of organs, most often in the pulmonary system; Vitamin B-12 deficiency, in which patients may have memory problems and unsteadiness; and Lupus, a chronic autoimmune disease in which the immune system turns against the body and harms healthy cells and tissues. Researchers are still trying to understand the cause of multiple sclerosis. It is still not known what causes the immune system to produce an abnormal reaction against cells in the brain and spinal cord. Normally, the immune system fights viruses and bacteria, but an abnormal immune system allows the body's white blood cells to destroy the myelin, thus leading to MS. In the late 1970s, researchers speculated that certain genes are associated with MS and may react with environmental factors to produce a condition that can lead to the destruction of the myelin, thus resulting in MS. Today, researchers believe the combination of heredity, the immune system, and possibly a virus may play a role in a person developing MS. Individuals may inherit a susceptibility to the disease, but not the disease itself. Fortunately, there are many drugs that can slow down the immune system attack and hopefully decrease the burden in patients with multiple sclerosis. " Treating patients with drugs like interferons and glatiramer acetate reduce the risk of having a subsequent attack, " Pary pointed out. " By modulating the immune system, we can decrease the chance of a relapse and hopefully decrease the amount of disability. " That again goes back to Pary's philosophy of neurology. He decided to study in the U.S. to receive the best training he thought possible. He did his residency at the University of Iowa, where he met his wife, the former Synhorst of Spencer, Iowa. She, too, was studying neurology and now also works as a neurologist after completing special training in stroke. Following his fellowship in neuromuscular disorders at Duke University, Durham, N.C., the couple decided to locate in the Midwest. Both have been associated with CNOS since August 2004. " I think the biggest change in the past 10 years in helping people with MS is that new treatment options are now available, " Pary stressed. " The medications work on the immune system, preventing further attacks of the disease on the brain cells. " He continued, " Many other treatments for multiple sclerosis are currently under study. Future medications may be even more promising. Our hope is that multiple sclerosis will be better treated and will become a less disabling disease. " http://www.siouxcityjournal.com/articles/2005/04/25/news/local/ 5a93eb6d6cd37fd586256fee0014808c.txt Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.